HADH Antibody (Center) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q16836 |
---|---|
Clone Names | 90723050 |
Gene ID | 3033 |
---|---|
Other Names | Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial, HCDH, Medium and short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase, Short-chain 3-hydroxyacyl-CoA dehydrogenase, HADH, HAD, HADHSC, SCHAD |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | HADH |
---|---|
Function | Mitochondrial fatty acid beta-oxidation enzyme that catalyzes the third step of the beta-oxidation cycle for medium and short-chain 3-hydroxy fatty acyl-CoAs (C4 to C10) (PubMed:10231530, PubMed:11489939, PubMed:16725361). Plays a role in the control of insulin secretion by inhibiting the activation of glutamate dehydrogenase 1 (GLUD1), an enzyme that has an important role in regulating amino acid-induced insulin secretion (By similarity). |
Cellular Location | Mitochondrion matrix |
Tissue Location | Expressed in liver, kidney, pancreas, heart and skeletal muscle. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
This gene is a member of the 3-hydroxyacyl-CoAdehydrogenase gene family. The encoded protein functions in themitochondrial matrix to catalyze the oxidation of straight-chain3-hydroxyacyl-CoAs as part of the beta-oxidation pathway. Itsenzymatic activity is highest with medium-chain-length fatty acids.Mutations in this gene cause one form of familial hyperinsulinemichypoglycemia. The human genome contains a related pseudogene ofthis gene on chromosome 15.
References
Kalsi, G., et al. Hum. Mol. Genet. 19(12):2497-2506(2010)Di Candia, S., et al. Eur. J. Endocrinol. 160(6):1019-1023(2009)van Hove, E.C., et al. Diabetes 55(11):3193-3196(2006)Yang, S.Y., et al. FEBS J. 272(19):4874-4883(2005)Vredendaal, P.J., et al. Mamm. Genome 9(9):763-768(1998)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.